Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
Titel:
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
Auteur:
Bianchini, D. Lorente, D. Rodriguez-Vida, A. Omlin, A. Pezaro, C. Ferraldeschi, R. Zivi, A. Attard, G. Chowdhury, S. de Bono, J.S.